Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Genitourinary Cancers
•
Medical Oncology
•
Renal Cell Carcinoma
How do you approach renal cell carcinoma with ipsilateral vs contralateral adrenal metastasis? Is there a role of surgery?
Related Questions
How do you reconcile the different trial results of KEYNOTE 574 and IMmotion010 for adjuvant checkpoint inhibitor use in RCC?
How would you treat a patient with metastatic RCC with high grade neuroendocrine and sarcomatoid features after progression on IO + TKI?
Do you routinely use a bone modifying agent in patients with metastatic RCC with bone metastases receiving a TKI?
How will you manage a patient with refractory metastatic unclassified RCC with progression on IO/TKI?
How do you treat clear cell renal cell carcinoma with metastatic recurrence while on adjuvant pembrolizumab?
How would you approach adjuvant systemic therapy for an isolated, oligometastatic CNS recurrence of RCC that was treated with SBRT?
Would you use adjuvant pembrolizumab for bilateral ccRCC with R1 resection?
When (if ever) would you re-challenge with immunotherapy for patients with metastatic RCC?
What is your treatment approach in localized RCC with VHL mutation after progression on belzutifan?
Do you routinely obtain next generation sequencing for patients with metastatic renal cell carcinoma and if so, what is your approach to incorporating these results into treatment decision making?
